Evidence map›Paper›PMID 41038831›Full record

ReviewNature reviews. Disease primers2025

Listeriosis.

Olivier Disson, Caroline Charlier, Philippe Pérot, Alexandre Leclercq, Ran Nir Paz, Sophia Kathariou, Yu-Huan Tsai, Marc Lecuit

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Disease primers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Differential virulence gene carriage inFrontiers in microbiology · 2026
    Article
  13. Article
  14. Genome-based taxonomic classification ofFrontiers in microbiology · 2026
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Olivier Disson *Institut Pasteur, Université Paris Cité, Inserm U1117, Biology of Infection Unit, Paris, France.
Caroline Charlier *Institut Pasteur, Université Paris Cité, Inserm U1117, Biology of Infection Unit, Paris, France.
Philippe PérotInstitut Pasteur, Université Paris Cité, Inserm U1117, Biology of Infection Unit, Paris, France.ORCID http://orcid.org/0000-0002-5194-8200
Alexandre LeclercqInstitut Pasteur, Listeria National Reference Center and WHO Collaborating Center, Paris, France.
Ran Nir PazHadassah-Hebrew University Medical Center, Jerusalem, Israel.
Sophia KathariouDepartment of Plant and Microbial Biology, North Carolina State University, Raleigh, NC, USA.
Yu-Huan TsaiDepartment of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan, Taiwan.ORCID http://orcid.org/0000-0002-1374-2359
Marc LecuitInstitut Pasteur, Université Paris Cité, Inserm U1117, Biology of Infection Unit, Paris, France. marc.lecuit@pasteur.fr.ORCID http://orcid.org/0000-0002-4491-1063

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Listeriosis is a serious food-borne bacterial infection caused by Listeria monocytogenes. L. monocytogenes is a facultative intracellular bacterial species that can replicate inside human cells, as well as thrive in a variety of environments, including soil, decaying vegetation, animal intestines and foods such as unpasteurized dairy products, soft cheese, raw meat, fish, seafood, vegetables and fruits. Clinically, L. monocytogenes can cause gastroenteritis in healthy individuals or serious invasive infections in at-risk populations. For example, maternal-fetal infections during pregnancy can lead to adverse pregnancy outcomes. In the elderly and immunosuppressed, listeriosis can cause septicaemia and central nervous system infections (also known as neurolisteriosis) with high mortality and risk of long-term sequelae. Genomic studies have identified four lineages of L. monocytogenes, with lineage I comprising the most virulent strains. The pathogenicity of L. monocytogenes reflects its ability to resist gastric and bile acids, colonize the intestinal lumen, cross the intestinal barrier, survive intracellularly in the bloodstream, evade immune responses, and cross the placental and blood-brain barriers. Diagnosis of listeriosis (septicaemia, neurolisteriosis, maternal-neonatal listeriosis or focal listeriosis) involves clinical observations and microbiological testing based on bacterial culture or DNA detection in individuals with prior antimicrobial therapy. Treatment typically involves aminopenicillins and aminoglycosides, with no evidence of clinically meaningful acquired antimicrobial resistance. Although listeriosis is a well-studied infection, a clearer picture of its global burden, its pathophysiology, the dynamics of the L. monocytogenes population and transmission routes is needed. On the host side, new risk factors, including genetics, and new treatment regimens to improve patient outcomes need to be identified.

Indexed as

ListeriosisAnti-Bacterial AgentsFemaleHumansListeria monocytogenesPregnancyAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.